CN101461550B - Spirulina tablet for student and preparation method thereof - Google Patents
Spirulina tablet for student and preparation method thereof Download PDFInfo
- Publication number
- CN101461550B CN101461550B CN2008100494364A CN200810049436A CN101461550B CN 101461550 B CN101461550 B CN 101461550B CN 2008100494364 A CN2008100494364 A CN 2008100494364A CN 200810049436 A CN200810049436 A CN 200810049436A CN 101461550 B CN101461550 B CN 101461550B
- Authority
- CN
- China
- Prior art keywords
- spirulina
- student
- profile
- tablet
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000016425 Arthrospira platensis Nutrition 0.000 title claims abstract description 46
- 240000002900 Arthrospira platensis Species 0.000 title claims abstract description 46
- 229940082787 spirulina Drugs 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 68
- 229960003080 taurine Drugs 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 32
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 38
- 240000006499 Flammulina velutipes Species 0.000 claims description 21
- 235000016640 Flammulina velutipes Nutrition 0.000 claims description 21
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 20
- 239000000377 silicon dioxide Substances 0.000 claims description 19
- 241001465754 Metazoa Species 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 10
- 241000195493 Cryptophyta Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 241000272194 Ciconiiformes Species 0.000 claims description 6
- 241000406668 Loxodonta cyclotis Species 0.000 claims description 6
- 208000025174 PANDAS Diseases 0.000 claims description 6
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 claims description 6
- 235000016496 Panda oleosa Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 2
- 240000000220 Panda oleosa Species 0.000 claims 2
- 235000013305 food Nutrition 0.000 abstract description 13
- 238000011161 development Methods 0.000 abstract description 8
- 230000018109 developmental process Effects 0.000 abstract description 8
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract description 5
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000008131 children development Effects 0.000 abstract description 3
- 210000002569 neuron Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 239000004472 Lysine Substances 0.000 description 5
- 210000004958 brain cell Anatomy 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 241000234427 Asparagus Species 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 4
- 240000004718 Panda Species 0.000 description 4
- 210000005013 brain tissue Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 210000003617 erythrocyte membrane Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010057315 Daydreaming Diseases 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 101000855583 Homo sapiens Cysteine sulfinic acid decarboxylase Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a health-care food and preparation thereof, especially discloses a spirulina tablet for student and preparation thereof. The spirulina tablet comprises 40-90 parts by weight of blunt top spirulina powder, 10-40 parts by weight of asparagus polysaccharide, 1-8 parts by weight of taurine, 0.02-0.09 parts by weight of docosahexaenoic acid, 1-6 parts by weight of excipient. The spirulina tablet is beneficial for children development, further capable of making adolescent strong, body shaped, keeping vigorous metabolism, promoting activity of a plurality of enzymes in the body, and making nerve cell develop normally. The tablet is further capable of promoting development of tissue and intelligence, enhancing learning and memorizing speed, and accuracy of memory.
Description
Technical field
The present invention relates to field of health care food, be specifically related to a kind of spirulina tablet for student and preparation method thereof.
Background technology
Children and teenager are in growth and development stage; Learning tasks are heavy, and the motion physical consumption is big, if diet nutritional is unreasonable; Then be prone to phenomenons such as generation is malnutritive, absent minded, decrease of memory, hypopsia; Certain nutrition lacks partially or imbalance also can be causeed fat disease, excessively becoming thin also can appear in the child of too partiality for a limited variety of food, particular about food and apocleisis.
Spirulina is the at present human optimal native protein food of finding, vegetable protein content is equivalent to 2 times of soybean up to 60～70%, and 3 times of beef are called as " king of protein ".The spirulina vegetable protein is made up of 18 amino acid, and wherein the human body self 8 kinds of contents of essential amino acids and the proportion of composing that can not synthesize all is superior to the ideal standard that FAO (Food and Agriculture Organization of the United Nation) (FAO) designs for the human food.Spirulina has almost comprised the various nutriments and the necessary various biological substances of development that promote health of all necessary for human, and is higher than human other edible at present food exponentially, can be rated as a natural nutrition treasure-house.Research shows: spirulina be human nutrition fullest known today, the most comprehensively, the most balancedly, the easiest be absorbed by the body that (absorptivity is up to 95%.) natural nutrient food.Be " green functional property nutrition treasure-house ".The contained nutrition of one gram spirulina is equivalent to the summation of all kinds of fruit vegetable nutrients of 1000 grams.The abundant nutrients of spirulina and equilibrium is of value to child development can also make the teenager with muscle-bound, keeps vigorous and graceful, keeps vigorous metabolism, promotes that plurality of enzymes maintains vigour in the body, and nerve cell is grown normal.
The spiral algae sheet that a plurality of brands are arranged in the market, but mostly be to be primary raw material with single spirulina.Its nutritional labeling is more single, and does not have the effect that promotes brain tissue and intelligence development.
Summary of the invention
The objective of the invention is to overcome the deficiency of the function singleness that has the spiral algae sheet existence now, a kind of spiral algae sheet that can promote brain tissue and intelligence development and preparation method thereof is provided.
The present invention seeks to realize through following technical scheme:
Spirulina tablet for student of the present invention is to be processed by the raw material of following weight parts:
Blunt top spirulina powder 40～90 weight portions
Flammulina velutipes 10～40 weight portions
Taurine 1～8 weight portion
DHA 0.02～0.09 weight portion
Excipients 1～6 weight portion.
Spirulina tablet for student of the present invention is preferably processed by the raw material of following weight parts:
Blunt top spirulina powder 59.95 weight portions
Flammulina velutipes 30 weight portions
Taurine 5 weight portions
DHA 0.05 weight portion
Excipients 5 weight portions.
Described excipients is silica or dolomol.Described excipients also can be the mixture of silica and dolomol, and the weight ratio of silica and dolomol is 0.1～0.6: 2.0～4.0.
Spiral algae sheet of the present invention is a cartoon abnormity sheet, is preferably 12 symbolic animals associated with a 12 year cycle profile or elephant profile or monkey profile or panda profile or penguin profile cartoon abnormity sheet.
The preparation method of spirulina tablet for student of the present invention is: after respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion, spirulina powder 40～90 weight portions; Flammulina velutipes 10～40 weight portions; Taurine 1～8 weight portion, DHA 0.02～0.09 weight portion, excipients 1～6 weight portion; Mix then, adopt full pressed powder technology compacting in flakes.
Described full pressed powder process using cartoon special-shaped mould is pressed into cartoon abnormity sheet.Described cartoon special-shaped mould is 12 symbolic animals associated with a 12 year cycle profile or elephant profile mould or monkey profile mould or panda profile mould or penguin profile mould.
The moisture of all components is controlled at 3～7% among the present invention.
All components of the present invention all be health ministry announce can be used for food or health food list, or the new resource food list is included kind.
The present invention has added flammulina velutipes in the spiral algae sheet health food, contain 53.9 milligrams of vitamin B2s, 10.9 milligrams of vitamin Cs in the bright Asparagus of per 100 grams; Contain protein 13 grams in the dried Asparagus of per 100 grams, carbohydrate 52 grams, mineral matter 7.56 grams.In addition, also contain carrotene, several amino acids, phytohemagglutin phytolectin, polysaccharide, taurine, the fast cry of certain animals of mushroom, tuber of dwarf lilyturf sterol, cytolysis toxin, dried mushroom cytotoxin etc.Need and self can not synthesize at human body, in 8 seed amino acids that must from food, absorb, lysine is most important a kind of, is described as " favourite son " in the protein families by the nutritionist.Lysine is to children growth, intelligence development, bone calcification and prevent that senile osteoporosis from all having obvious effects.But lysine is comparatively to lack in the meals of leading in cereal especially in food.And lysine content is higher than other mushroom class in the Asparagus; So often use Asparagus; But required lysine amount in the added body to promoting infant, teen-age growing, increases brain nutrition; Improve IQ and intelligence, strengthen thinking ability, memory, build up health and the muscle tolerance is undoubtedly of great advantage.
The taurine that adds in the health food of the present invention has following function: (1) promotes infant brain tissue and intelligence development: the content of taurine in brain is abundant, distribution is extensive; Can obviously promote neural growing and cell proliferation, differentiation; And be dose dependent, in the cranial nerve cell growth course, play an important role.Research shows: the content of taurine in premature's brain is starkly lower than the term infant, and this is because half skin propylhomoserin sulfinic acid dehydrogenase (CSAD) undeveloped mature still in premature's body, and synthesizing taurine is not enough to satisfy the needs of body, needs to be replenished by breast milk.(2) improve endocrinosity, enhances human body immunity: taurine can promote the pituitrin secretion, the activation pancreas function, thereby improve the state of organism endocrine system, to organism metabolism with useful adjusting; And have the enhancing that promotes organism immunity and an effect of antifatigue.(3) improve the function of remembering: find that in the animal experiment study of taurine and brain growth relation taurine can promote the learning and Memory ability of big white mouse.Replenish an amount of taurine and not only can improve learning and memory speed, but also can improve the accuracy of learning and memory, and to neural anti-ageing certain effect that also has.(4) other functions: taurine is prevented and treated hypoferric anemia has positive effect, and it not only can promote the absorption of enteron aisle to iron, also can increase the stability of erythrocyte membrane; Taurine still is the short living factor of bifid bacterium in the human body intestinal canal, optimizes bacterial flora structure in the enteron aisle; Also has anti-oxidant, delaying senility function; Can promote oxyhepatitis to recover normal; Carbon tetrachloride poisoning there is protective effect, and can suppresses the rising of the caused thus serum paddy third special ammonia enzyme.Renal toxicity is had protective effect, and taurine changes the renal cells of former generation of the rabbit due to the cis-platinum has protective effect; Other has report, and taurine can be calm, analgesia and anti-inflammatory, and frostbite, KCN are poisoned and migraines also has preventive and therapeutic effect.
The DHA that adds has following effect: (1) anti-aging effects: research shows that along with increasing age, DHA, EPA content reduce in human blood platelets, the erythrocyte membrane lipid, and SOD is active to be reduced; 12 the elderlys take DHA, EPA fish oil preparation after 4 weeks, and DHA, EPA content increase the SOD increased activity in its erythrocyte membrane lipid.Also there are research work prompting DHA and EPA to have anti-oxidant, anti-aging effects.(2) strengthen in the phosphatide that cerebral function: DHA is present in brain in a large number (10% of big cephalin is DHA).Phosphatide plays an important role in the formation of brain cell and structure.As lack DHA, and neuronic projection promptly can not be kept, and formed desmachyme is impaired, and transmission information is not smooth, and memory, thinking ability etc. can affect adversely, and brain will fail in advance.Experiment showed, that the younger mouse of DHA content is low in the aged mouse brain, replenish after the DHA for aged mouse in a large number, can make that DHA content increases in its brain, the brain cell atrophy is prevented, even the brain cell projection grown again, and intelligence and memory improve.Feed and raise the mouse of DHA, its sense of smell, search capability, judgment all are improved in the labyrinth.The elderly takes the health products that contain DHA more, often can make rudimentary cerebral nerve function, memory obtain certain recovery.DHA also is the important substance of fetal brain cell division, propagation, growth.The infant can cause slow, the feeblemindedness of brain cell development as lacking DHA.Can be used for brain boosting and supplementing, improve memory and thinking ability, failure of memory, senile dementia are had certain curative effect.Still the nourishing healthy that can be used for the infant in addition.(3) improve blood circulation: DHA, EPA can suppress platelet aggregation, make that thrombosis is obstructed, blood viscosity descends, and blood circulation improves, and makes blood pressure drops.This function EPA is superior to DHA, and the two all can be used for preventing and treating cerebral thrombus, lower limb Arteriosclerosis obliterans.(4) reducing blood lipid: DHA, EPA can reduce serum total cholesterol and LDL-C. and increase HDL-C, can treat hyperlipemia, atherosclerotic etc.
Because the present invention adopts above-mentioned prescription, compared with prior art, the present invention has following beneficial effect: be of value to child development; Can also make the teenager with muscle-bound; Keep vigorous and graceful, keep vigorous metabolism, promote the vigor of plurality of enzymes in the body and nerve cell to grow normal; Promote the accuracy of brain tissue and intelligence development, raising learning and memory speed and memory, improve phenomenons such as malnutritive, absent minded, decrease of memory, hypopsia.Most of children has the psychology of repulsion to the health food of similar tablet in addition, and spiral algae sheet of the present invention is processed cartoon abnormity sheet, can attract children's notice, eliminates the repulsion to spiral algae sheet, and it is edible to be easy to children.
The specific embodiment
Below in conjunction with embodiment the present invention is elaborated.
Embodiment 1
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 40 weight portions
Flammulina velutipes 40 weight portions
Taurine 5 weight portions
DHA 0.05 weight portion,
The silica 1 weight portion.
Then said components is mixed, adopt full pressed powder technology, be pressed into elephant profile cartoon with elephant profile mould.
Embodiment 2
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 50 weight portions
Flammulina velutipes 20 weight portions
Taurine 4 weight portions
DHA 0.02 weight portion,
Silica 6 weight portions.
Then said components is mixed, adopt full pressed powder technology, be pressed into monkey profile cartoon with monkey profile mould.
Embodiment 3
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 60 weight portions
Flammulina velutipes 10 weight portions
Taurine 7 weight portions
DHA 0.03 weight portion,
Silica 6 weight portions.
Then said components is mixed, adopt full pressed powder technology, be pressed into panda profile cartoon with panda profile mould.
Embodiment 4
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 70 weight portions
Flammulina velutipes 15 weight portions
Taurine 8 weight portions
DHA 0.08 weight portion,
Dolomol 1 weight portion.
Then said components is mixed, adopt full pressed powder technology, be pressed into penguin profile cartoon with penguin profile mould.
Embodiment 5
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 80 weight portions
Flammulina velutipes 30 weight portions
Taurine 1 weight portion
DHA 0.09 weight portion,
Dolomol 4 weight portions.
Then said components is mixed, adopt full pressed powder technology, be pressed into 12 symbolic animals associated with a 12 year cycle profile cartoon with 12 symbolic animals associated with a 12 year cycle profile mould respectively.
Embodiment 6
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 90 weight portions
Flammulina velutipes 25 weight portions
Taurine 2 weight portions
DHA 0.06 weight portion,
Dolomol 6 weight portions.
Then said components is mixed, adopt full pressed powder technology, be pressed into 12 symbolic animals associated with a 12 year cycle profile cartoon with 12 symbolic animals associated with a 12 year cycle profile mould respectively.
Embodiment 7
After respectively 60～100 sieves are pulverized, crossed to spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion:
Spirulina powder 90 weight portions
Flammulina velutipes 25 weight portions
Taurine 2 weight portions
DHA 0.06 weight portion,
Dolomol 6 weight portions.
Then said components is mixed, adopt full pressed powder technology, be pressed into 12 symbolic animals associated with a 12 year cycle profile cartoon with 12 symbolic animals associated with a 12 year cycle profile mould respectively.
Embodiment 8
Repeat the method for embodiment 1, different is to adopt the mixture of silica and dolomol as excipients, and the weight ratio of silica and dolomol is 0.1: 2.0, amounts to 6 weight portions.
Embodiment 9
Repeat the method for embodiment 2, different is to adopt the mixture of silica and dolomol as excipients, and the weight ratio of silica and dolomol is 0.6: 2.0, amounts to 5 weight portions.
Embodiment 10
Repeat the method for embodiment 3, different is to adopt the mixture of silica and dolomol as excipients, and the weight ratio of silica and dolomol is 0.1: 4.0, amounts to 4 weight portions.
Embodiment 11
Repeat the method for embodiment 4, different is to adopt the mixture of silica and dolomol as excipients, and the weight ratio of silica and dolomol is 0.6: 4.0, amounts to 2 weight portions.
Embodiment 12
Repeat the method for embodiment 4, different is to adopt the mixture of silica and dolomol as excipients, and the weight ratio of silica and dolomol is 0.5: 3.5, amounts to 1 weight portion.
Claims (9)
1. spirulina tablet for student is characterized in that it is to be processed by the raw material of following weight parts:
2. spirulina tablet for student according to claim 1 is characterized in that it is to be processed by the raw material of following weight parts:
3. spirulina tablet for student according to claim 1 and 2 is characterized in that: described excipients is silica or dolomol.
4. spirulina tablet for student according to claim 1 and 2 is characterized in that: described excipients is the mixture of silica and dolomol, and the weight ratio of silica and dolomol is 0.1～0.6: 2.0～4.0.
5. spirulina tablet for student as claimed in claim 1 is characterized in that: described spiral algae sheet is a cartoon abnormity sheet.
6. spirulina tablet for student as claimed in claim 5 is characterized in that: described spiral algae sheet is 12 symbolic animals associated with a 12 year cycle profile or elephant profile or panda profile or penguin profile cartoon abnormity sheet.
7. the preparation method of spirulina tablet for student as claimed in claim 5; It is characterized in that: after respectively 60～100 sieves are pulverized, crossed to blunt top spirulina powder, flammulina velutipes, taurine and DHA, take by weighing each component by following weight portion, blunt top spirulina powder 40～90 weight portions; Flammulina velutipes 10～40 weight portions; Taurine 1～8 weight portion, DHA 0.02～0.09 weight portion, excipients 1～6 weight portion; Mix then, adopt full pressed powder technology compacting in flakes.
8. the preparation method of spirulina tablet for student according to claim 7 is characterized in that: described full pressed powder process using cartoon special-shaped mould is pressed into cartoon abnormity sheet.
9. the preparation method of spirulina tablet for student according to claim 8, it is characterized in that: described cartoon special-shaped mould is 12 symbolic animals associated with a 12 year cycle profile mould or elephant profile mould or panda profile mould or penguin profile mould.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100494364A CN101461550B (en) | 2008-03-28 | 2008-03-28 | Spirulina tablet for student and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100494364A CN101461550B (en) | 2008-03-28 | 2008-03-28 | Spirulina tablet for student and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101461550A CN101461550A (en) | 2009-06-24 |
| CN101461550B true CN101461550B (en) | 2012-07-25 |
Family
ID=40802499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100494364A Expired - Fee Related CN101461550B (en) | 2008-03-28 | 2008-03-28 | Spirulina tablet for student and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101461550B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102150860B (en) * | 2010-12-28 | 2012-11-28 | 北京同仁堂健康药业股份有限公司 | Composition for easing visual fatigue and assisting in improving memory |
| CN104305365A (en) * | 2014-11-06 | 2015-01-28 | 王裴玲 | Instant spirulina tablets and preparation method thereof |
| CN104522750A (en) * | 2014-12-18 | 2015-04-22 | 威海百合生物技术股份有限公司 | Alga healthcare food |
| GB2547241A (en) * | 2016-02-11 | 2017-08-16 | Akl Res & Dev Ltd | Anti-inflammatory formulation |
| CN107801680A (en) * | 2017-09-18 | 2018-03-16 | 芜湖新华联文化旅游开发有限公司 | A kind of gentoo disease prevention and cure method |
-
2008
- 2008-03-28 CN CN2008100494364A patent/CN101461550B/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 邱春吟.我国螺旋藻开发现状与展望.《湛江海洋大学学报》.1997,78－80. |
| 马贵武 |
| 马贵武;邱春吟.我国螺旋藻开发现状与展望.《湛江海洋大学学报》.1997,78-80. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101461550A (en) | 2009-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100391353C (en) | Formula milk powder for babies | |
| CN104544432B (en) | Samara oil compound protein solid beverage and method for preparing same | |
| CN109287759A (en) | A kind of formula milk and production method helping child height development | |
| CN111011691A (en) | High-protein high-fiber solid beverage | |
| CN108142927A (en) | It is a kind of to be used to meet composition of motion control weight demand and preparation method thereof | |
| CN101461550B (en) | Spirulina tablet for student and preparation method thereof | |
| CN102511720A (en) | Stachyose infant nourishing cereal and its preparation method | |
| CN102429307A (en) | Low-calorie and total-nutrient beverage and preparation method thereof | |
| CN110754655A (en) | Low-fat type total nutrient formula and preparation method thereof | |
| CN106615690A (en) | Nutrient paste for improving pet anemia symptom, and preparation method and application thereof | |
| Alina et al. | Food fortification through innovative technologies | |
| CN1209031C (en) | Milk powder for preschool children | |
| CN115251373A (en) | Special dietary food for controlling weight, preparation process and application thereof | |
| JP2018507709A (en) | Mineral reinforced natural supplement | |
| CN101791123B (en) | Health care product abundant in vitamin B and vitamin C and preparation method thereof | |
| Cimmino et al. | Role of Milk Micronutrients in Human Health | |
| CN110604218A (en) | Formula and preparation method of pet nutrition paste | |
| CN109077304A (en) | Pine needle ferment, preparation method and decompression full nutrition formula food and eating method | |
| CN103392799B (en) | Castanea mollissima peptide lactic acid bacteria beverage and preparation method thereof | |
| CN109527093A (en) | A kind of infant nutrient packet special diet product and preparation method thereof | |
| CN102057985A (en) | Flammulina velutipes health-care acidophilus milk | |
| KR102266858B1 (en) | Manufacturing method of feed for layer chicken | |
| CN113615740A (en) | Meal replacement milk shake capable of controlling energy and regulating emotion and preparation method thereof | |
| CN1046085A (en) | The production method of plant milk | |
| CN101147507A (en) | Method for manufacturing double-protein nutrient dairy product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |